NCT00003358View on ClinicalTrials.gov

Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 1998

Primary Completion Date

January 31, 2001

Conditions

Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer

Interventions

DRUG

chemotherapy

DRUG

cisplatin

DRUG

gemcitabine hydrochloride

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003358 - Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter